1,446 results on '"Bartlett, David L."'
Search Results
2. Normal CEA Levels After Neoadjuvant Chemotherapy and Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from Colorectal Peritoneal Metastases
3. Characterizing the Immune Environment in Peritoneal Carcinomatosis: Insights for Novel Immunotherapy Strategies
4. Advanced Care Planning Prior to Oncologic Surgery: An Assessment of Utilization and Implications
5. ASO Visual Abstract: Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH-Sensitive Imaging Agent—Final Results from a Phase 2 Study
6. Exploring the Perception of Value in Cancer Care: A Comparison of Patients, Providers, and Payers
7. ASO Visual Abstract: Normal CEA Levels After Neoadjuvant Chemotherapy and Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from Colorectal Peritoneal Metastases
8. Defining the Values and Quality of Life of Cancer Survivors Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An International Survey Study
9. Targeted Next-Generation Sequencing Improves the Prognostication of Patients with Disseminated Appendiceal Mucinous Neoplasms (Pseudomyxoma Peritonei)
10. Cover
11. Frontmatter
12. 6. Structural Adjustment in Hungary's New Democracy
13. Index
14. 5. Stabilization Policy in the Postcommunist Period
15. 7. Implications and Comparative Perspectives
16. Part 3: Economic Reform in Democratic Hungary, 1990−94
17. Part 4: Conclusions
18. 2. Macroeconomic Stabilization under Reform Communism
19. Appendix
20. 4. Political Institutions and Hungary's Negotiated Transition
21. Part 2: Economic Reform in Communist Hungary, 1979−89
22. 3. Structural Adjustment and Market Socialism
23. Part 1: An Institutional Approach to Eastern Europe's Transition
24. 1. Party and State Institutions in Dual Transformations
25. Tables
26. ASO Visual Abstract: Characterizing the Immune Environment in Peritoneal Carcinomatosis—Insights for Novel Immunotherapy Strategies
27. Intra-pleural and intra-peritoneal tocilizumab therapy for managing malignant pleural effusions and ascites: The Regional Immuno-Oncology Trial (RIOT)−2 study protocol
28. Intra-tumoral immunomodulatory therapy for advanced abdominal cancers using lipopolysaccharide: The Regional Immuno-Oncology Trial-1 (RIOT-1) protocol (NCT05751837)
29. Assessing the long-term priorities of pancreaticoduodenectomy survivors
30. Predicting Severe Complications from Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: A Data-Driven, Machine Learning Approach to Augment Clinical Judgment
31. ASO Visual Abstract: Targeted Next-Generation Sequencing Improves the Prognostication of Patients with Disseminated Appendiceal Mucinous Neoplasms (Pseudomyxoma Peritonei)
32. Comprehensive value implications of surgeon volume for lung cancer surgery: Use of an analytic framework within a regional health system
33. Impact of Primary Tumor Location and Genomic Alterations on Survival Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Colorectal Peritoneal Metastases
34. Microsatellite instability should not determine candidacy for cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion in patients with peritoneal metastases from colorectal cancer
35. Socioeconomic Factors Predict Long-Term Quality of Life of Cancer Survivors: An International Survey
36. ASO Visual Abstract: Defining the Values and Quality of Life of Cancer Survivors Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An International Survey Study
37. ASO Visual Abstract: Impact of Primary Tumor Location and Genomic Alterations on Survival Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Colorectal Peritoneal Metastases
38. ASO Author Reflections: Augmenting Clinical Decision-Making Around Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Through Traditional and Machine Learning Algorithms
39. ASO Visual Abstract: Predicting Severe Complications from Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy—A Data-Driven, Machine Learning Approach to Augment Clinical Judgement
40. Intratumoral Delivery of Interleukin 9 via Oncolytic Vaccinia Virus Elicits Potent Antitumor Effects in Tumor Models
41. Failure to Thrive Following Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy: Causes and Consequences
42. Impact of Neoadjuvant Therapy on Survival Following Margin-Positive Resection for Pancreatic Cancer
43. Optimal Management of Resectable Pancreatic Head Cancer in the Elderly Patient: Does Neoadjuvant Therapy Offer a Survival Benefit?
44. Predischarge Prediction of Readmission After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Derivation and Validation of a Risk Prediction Score
45. IL-36γ-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunity
46. Phase II Trial of Adjuvant Dendritic Cell Vaccine in Combination with Celecoxib, Interferon-α, and Rintatolimod in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases
47. Supplementary Table S12 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
48. Supplementary Figure S7 from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
49. Data from Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
50. Novel Techniques and the Future of HIPEC (Immunotherapy, Viral Therapy)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.